Table 2.

Distribution of HPV16 in HNSCCs at different anatomical locations

Anatomical site	HPV16 L1 DNA	Percent	HPV16 E6/E7 DNA	Percent
Larynx (n = 16)	6	37.5	8	50
Oropharynx (n = 15)	9	60	9	60
Hypopharynx (n = 5)	2	40	1	20
Oral cavity (n = 4)	2	50	3	75
Other (n = 2)	0	0	0	0
Total (n = 42)	19	100	21	100

There was no association between the detection of HPV16 DNA and tumour site